| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, Texas 77550-2774
Target organ-specific estrogen-induced DNA adducts were previously shown to precede renal carcinogenesis in Syrian hamsters. Because estrogens induced these DNA modifications, but were not part of the adduct structure, free radical activation of endogenous electrophiles was postulated as a mechanism of tumor induction by estrogens. In the present study, the activities of enzymes which detoxify reactive intermediates were studied in liver and kidney of hamsters treated with estradiol for 1, 2, and 4 mo and in untreated controls. These studies were done to detect oxidative stress in the target organ of carcinogenesis. In the estrogenexposed hamster kidney (1, 2, and 4 mo), activities of glutathione peroxidases I and II were significantly increased. The activity of catalase was decreased compared to those in untreated controls. In livers which are not the target organ of carcinogenesis, treatment of hamsters with estrogen for 1, 2, and 4 mo resulted in changes of activities of glutathione peroxidases I and II and catalase, which were opposite to the pattern found in the kidney. Activities of superoxide dismutase, glutathione reductase, glucose-6-phosphate dehydrogenase,
-glutamyl transpeptidase, and glutathione transferase in estradiol-treated hamster liver and kidney did not differ significantly from those in either liver or kidney of untreated age-matched controls. Fluorescent products of lipid peroxidation more than doubled in the kidney, but not in the liver of hamsters treated with estradiol for 1 mo. It is concluded that the increases in glutathione, in the activity of glutathione peroxidase, and in products of lipid peroxidation in the kidneys of hamsters treated chronically with estrogen all point towards elevated levels of oxidative stress.
1 This work was supported by grants from the National Cancer Institute, NIH (CA43232, CA43233, and CA44069).
2 To whom requests for reprints should be addressed, at Department of Pharmacology and Toxicology, The University of Texas Medical Branch, Galveston, TX 77550-2774.
Received 4/ 7/88. Revised 9/26/88. Revised 12/15/88. Accepted 12/20/88.
This article has been cited by other articles:
![]() |
J. A. Canter, A. R. Kallianpur, F. F. Parl, and R. C. Millikan Mitochondrial DNA G10398A Polymorphism and Invasive Breast Cancer in African-American Women Cancer Res., September 1, 2005; 65(17): 8028 - 8033. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Ha and A. M. Smith Plasma Selenium and Plasma and Erythrocyte Glutathione Peroxidase Activity Increase with Estrogen during the Menstrual Cycle J. Am. Coll. Nutr., February 1, 2003; 22(1): 43 - 51. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. FAUCHER, L. LACOSTE, and V. LUU-THE Human Type 1 Estrogen Sulfotransferase: Catecholestrogen Metabolism and Potential Involvement in Cancer Promotion Ann. N.Y. Acad. Sci., June 1, 2002; 963(1): 221 - 228. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Zhu and J. G. Liehr Inhibition of Catechol O-Methyltransferase-catalyzed O-Methylation of 2- and 4-Hydroxyestradiol by Quercetin J. Biol. Chem., January 19, 1996; 271(3): 1357 - 1363. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |